BPBruno Sachetto Paulo

Bruno Sachetto Paulo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruno Sachetto Paulo has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IDBac: an open-access web platform to identify bacteria and analyze relationships in culture collections using MALDI-TOF mass spectrometry

    by Nyssa K. Krull, Michael Strobel, Julia Saulog, Liana Zaroubi, Bruno S. Paulo, Mandisa Timba, Douglas R. Braun, Gabrielle Mingolelli, Jessia Raherisoanjato, Robert A. Shepherd, et al.

    The identification and analysis of bacteria is central to the microbiological sciences. While gene sequencing methods have been the standard to achieve this, use of MALDI-TOF mass spectrometry (MS), particularly in clinical microbiology, can provide high-throughput identification to the subspecies level. However, biotyping has yet to be adopted outside of clinical settings due to the lack of a centralized public database of MS protein signatures that would facilitate isolate identification via spectral comparison. Further, most current MALDI MS data analysis platforms lack meaningful ways to compare properties from large numbers of bacterial isolates. Herein we present the IDBac web platform, a crowd-sourced central knowledgebase of protein MS signatures spanning seven bacterial phyla. Accompanying the knowledgebase is analysis infrastructure to identify unknown isolates, probe relationships within culture collections using metadata integration, and visualize specialized metabolite differences within groups of closely related bacteria. To highlight this utility and encourage wide community contribution, examples of each are presented.


  • Comparative Genomics and Metabolomics of Domesticated, Pladienolide-Producing Streptomyces Bacteria

    by Barbara I. Adaikpoh, Taylor Kornfuehrer, Yitao Dai, Galen Ptacek, Bruno S. Paulo, Talia Cheifetz, Brendan Duggan, James J. La Clair, Michael D. Burkart, Alessandra S. Eustáquio

    Laboratory domestication of bacteria can negatively affect natural product production. This problem continues to plague discovery and development efforts. In this study, we investigated pladienolides from Streptomyces platensis, synthetic derivatives of which entered clinical trials for the treatment of acute myeloid leukemia. Solid cultures of the deposited S. platensis Mer-11107 yielded black, gray, and white colonies with identical 16S rRNA gene sequences, revealing that they were the same species. Importantly, metabolite analysis identified one white isolate with a 3-fold improvement in pladienolide B titers. Experimental evolution of black isolates gave rise to both gray and white colonies. In contrast, gray and white isolates did not generate the black phenotype, suggesting black isolates are ancestral strains and that the mechanism underlying the phenotypic heterogeneity is irreversible. Comparative genomics revealed sequence and structure variations that may help explain the observed differences in development and metabolite production. The increase in pladienolide titers with the white isolate is in line with the recent concept of division of labor within Streptomyces colonies, where genomic instability results in some cells specializing in antibiotic production and others remaining reproductive. Ultimately, identification of the pladienolide B overproducer will facilitate future studies in this important class of splice-modulating antitumor agents.


  • Open Access

    IDBac: an open-access web platform to identify bacteria and analyze relationships in culture collections using MALDI-TOF mass spectrometry

    by Nyssa K. Krull, Michael Strobel, Julia Saulog, Liana Zaroubi, Bruno S. Paulo, Mandisa Timba, Douglas R. Braun, Gabrielle Mingolelli, Jessia Raherisoanjato, Robert A. Shepherd, et al.

    The identification and analysis of bacteria is central to the microbiological sciences. While gene sequencing methods have been the standard to achieve this, use of MALDI-TOF mass spectrometry (MS), particularly in clinical microbiology, provides high-throughput identification to the subspecies level. However, biotyping has yet to be adopted outside of clinical settings due to the lack of a centralized public database of MS protein signatures that would facilitate isolate identification via spectral comparison. Further, current platforms lack meaningful ways to compare multiple properties from large numbers of bacterial isolates. Herein we present the IDBac web platform, a crowd-sourced central knowledgebase of protein MS signatures of >1400 strains spanning 6 bacterial phyla. Accompanying the knowledgebase is analysis infrastructure to identify unknown isolates, probe relationships within culture collections using metadata integration, and visualize specialized metabolite differences within groups of closely related bacteria. To highlight this utility and encourage wide community contribution, examples of each are presented.


  • Open Access

    Discovery of megapolipeptins by genome mining of a Burkholderiales bacteria collection

    by Bruno S. Paulo, Michael Joseph John Recchia, Sanghoon Lee, Claire H. Fergusson, Sean B. Romanowski, Antonio Hernandez, Nyssa Krull, Dennis Y. Liu, Hannah Cavanagh, Allyson Bos, et al.

    Megapolipeptins show low structural similarity to known natural products, highlighting the advantage of our Burkholderiales genomics-driven and synthetic biology-enabled pipeline to discover novel natural products.


  • Open Access

    Discovery of megapolipeptins by genome mining of a Burkholderiales bacteria collection

    by Bruno Paulo, Michael Recchia, Sanghoon Lee, Claire Fergusson, Sean Romanowski, Antonio Hernandez, Nyssa Krull, Dennis Liu, Hannah Cavanagh, Allyson Bos, et al.

    Burkholderiales bacteria have emerged as a promising source of structurally diverse natural products that are expected to play important ecological and industrial roles. This order ranks in the top three in terms of predicted natural product diversity from available genomes, warranting further genome sequencing efforts. However, a major hurdle in obtaining the predicted products is that biosynthetic genes are often ‘silent’ or poorly expressed. Here we report complementary strain isolation, genomics, metabolomics, and synthetic biology approaches to enable natural product discovery. First, we built a collection of 316 rhizosphere-derived Burkholderiales strains over the course of five years. We then selected 115 strains for sequencing using the mass spectrometry pipeline IDBac to avoid strain redundancy. After predicting and comparing the biosynthetic potential of each strain, a biosynthetic gene cluster that was silent in the native Paraburkholderia megapolitana and Paraburkholderia acidicola producers was cloned and activated by heterologous expression in a Burkholderia sp. host, yielding megapolipeptins A and B. Megapolipeptins are unusual polyketide, nonribosomal peptide, and polyunsaturated fatty acid hybrids that show low structural similarity to known natural products, highlighting the advantage of our Burkholderiales genomics-driven and synthetic biology-enabled pipeline to discover novel natural products.

  • Open Access

    Identification of the lipodepsipeptide selethramide encoded in a giant nonribosomal peptide synthetase from aBurkholderiabacterium

    by Sean B. Romanowski, Sanghoon Lee, Sylvia Kunakom, Bruno S. Paulo, Michael J. J. Recchia, Dennis Y. Liu, Hannah Cavanagh, Roger G. Linington, Alessandra S. Eustáquio

    Bacterial natural products have found many important industrial applications. Yet traditional discovery pipelines often prioritize individual natural product families despite the presence of multiple natural product biosynthetic gene clusters in each bacterial genome. Systematic characterization of talented strains is a means to expand the known natural product space. Here, we report genomics, epigenomics, and metabolomics studies ofBurkholderiasp. FERM BP-3421, a soil isolate and known producer of antitumor spliceostatins. Its genome is composed of two chromosomes and two plasmids encoding at least 29 natural product families. Metabolomics studies showed that FERM BP-3421 also produces antifungal aminopyrrolnitrin and approved anticancer romidepsin. From the orphan metabolome features, we connected a lipopeptide of 1,928 Da to an 18-module nonribosomal peptide synthetase encoded as a single gene in chromosome 1. Isolation and structure elucidation led to the identification of selethramide which contains a repeating pattern of serine and leucine and is cyclized at the side chain oxygen of the one threonine residue at position 13. A (R)-3-hydroxybutyric acid moiety decorates theN-terminal serine. Initial attempts to obtain deletion mutants to probe the role of selethramide failed. After acquiring epigenome (methylome) data for FERM BP-3421, we employed a mimicry by methylation strategy that improved DNA transfer efficiency. Mutants defective in selethramide biosynthesis showed reduced surfactant activity and impaired swarming motility that could be chemically complemented with selethramide. This work unveils a lipopeptide that promotes surface motility, establishes improved DNA transfer efficiency, and sets the stage for continued natural product identification from a prolific strain.


  • New Cyclodepsipeptide Derivatives Revealed by Genome Mining and Molecular Networking

    by Bruno S. Paulo, Renata Sigrist, Célio F. F. Angolini, Luciana G. De Oliveira

    Genome mining and molecular networking analyses have revealed a renewed capacity to uncover molecules and biosynthetic pathways from bacterial secondary metabolism. The present study describes the association of genome mining and molecular networking to correlate production of valinomycin cyclodepsipeptide derivatives by Streptomyces sp. CBMAI 2042. Additionally, expression of the entire gene cluster in a heterologous host successfully allowed the association of this biosynthetic assembly to the production of montanastatin, valinomycin and at least five structural analogues, revealing a plasticity of the modules and an interesting thioesterase activity capable of assembling two or three units of the tetradepsipeptide monomer.


  • Open Access

    Whole-Genome Sequence of the Endophytic Streptomyces sp. Strain CBMAI 2042, Isolated from Citrus sinensis

    by Luciana Gonzaga de Oliveira, Renata Sigrist, Bruno Sachetto Paulo, Markyian Samborskyy

    The whole-genome sequence of Streptomyces sp. strain CBMAI 2042, an endophytic actinobacterium isolated from Citrus sinensis branches, is described.


  • Open Access

    Gene Deletion Leads to Improved Valinomycin Production by Streptomyces sp. CBMAI 2042

    by Bruno Paulo, Renata Sigrist, Célio Angolini, Marcos Eberlin, Luciana de Oliveira